• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长抑素、麻醉与类癌综合征。围手术期给予生长抑素类似物以抑制类癌肿瘤活性。

Somatostatin, anaesthesia, and the carcinoid syndrome. Peri-operative administration of a somatostatin analogue to suppress carcinoid tumour activity.

作者信息

Roy R C, Carter R F, Wright P D

出版信息

Anaesthesia. 1987 Jun;42(6):627-32. doi: 10.1111/j.1365-2044.1987.tb03087.x.

DOI:10.1111/j.1365-2044.1987.tb03087.x
PMID:2887127
Abstract

A patient with carcinoid syndrome on long-term antiserotonin therapy with parachlorophenylalanine, experienced a flushing attack with hypotension during the prophylactic administration of aprotonin prior to the induction of anaesthesia. When she was subsequently prepared with a long-acting somatostatin analogue, octreotide (Sandostatin, Sandoz SMS 201-995), plasma levels of tumour-released hormones were reduced and anaesthesia for resection of hepatic metastases was uneventful. The advantages of an anaesthetic approach based on inhibition of carcinoid tumour activity, rather than antagonism of released hormones, are discussed.

摘要

一名长期使用对氯苯丙氨酸进行抗血清素治疗的类癌综合征患者,在麻醉诱导前预防性给予抑肽酶时发生了伴有低血压的潮红发作。随后当她使用长效生长抑素类似物奥曲肽(善宁,山德士SMS 201-995)进行准备时,肿瘤释放激素的血浆水平降低,肝转移瘤切除的麻醉过程顺利。本文讨论了基于抑制类癌肿瘤活性而非拮抗释放激素的麻醉方法的优点。

相似文献

1
Somatostatin, anaesthesia, and the carcinoid syndrome. Peri-operative administration of a somatostatin analogue to suppress carcinoid tumour activity.生长抑素、麻醉与类癌综合征。围手术期给予生长抑素类似物以抑制类癌肿瘤活性。
Anaesthesia. 1987 Jun;42(6):627-32. doi: 10.1111/j.1365-2044.1987.tb03087.x.
2
Pre-treatment with somatostatin in the anaesthetic management of a patient with carcinoid syndrome.
Can J Anaesth. 1988 Jul;35(4):413-6. doi: 10.1007/BF03010865.
3
Uneventful spinal anesthesia for a patient with carcinoid syndrome managed with long-acting octreotide.长效奥曲肽治疗类癌综合征患者的脊髓麻醉过程顺利。
Can J Anaesth. 2002 Aug-Sep;49(7):678-81. doi: 10.1007/BF03017444.
4
Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.恶性类癌综合征的治疗。一种长效生长抑素类似物的评估。
N Engl J Med. 1986 Sep 11;315(11):663-6. doi: 10.1056/NEJM198609113151102.
5
[Symptomatic treatment of the malignant carcinoid syndrome with octreotide].用奥曲肽对恶性类癌综合征进行对症治疗
S Afr Med J. 1989 Jan 7;75(1):30-1.
6
Use of a somatostatin analogue in association with surgery and hepatic arterial embolisation in the treatment of the carcinoid syndrome.生长抑素类似物联合手术及肝动脉栓塞术治疗类癌综合征
Br J Cancer. 1987 Dec;56(6):840-2. doi: 10.1038/bjc.1987.302.
7
Rapid reversal of carcinoid crisis with a somatostatin analogue.
N Engl J Med. 1985 Nov 7;313(19):1229-30. doi: 10.1056/NEJM198511073131915.
8
Orthotopic liver transplantation for carcinoid tumour metastatic to the liver: anesthetic management.肝类癌转移的原位肝移植:麻醉管理
Can J Anaesth. 2000 Apr;47(4):334-7. doi: 10.1007/BF03020948.
9
The prophylactic use of octreotide in a patient with ovarian carcinoid and valvular heart disease.奥曲肽在一名患有卵巢类癌和心脏瓣膜病患者中的预防性应用。
Can J Anaesth. 1990 Oct;37(7):798-800. doi: 10.1007/BF03006540.
10
[A favorable response to the somatostatin analog SMS 201-995 in a patient with the carcinoid syndrome].[一名类癌综合征患者对生长抑素类似物SMS 201-995产生良好反应]
Rev Esp Enferm Dig. 1991 Mar;79(3):215-7.

引用本文的文献

1
Perioperative Carcinoid Crisis: A Systematic Review and Meta-Analysis.围手术期类癌危象:一项系统评价与荟萃分析。
Cancers (Basel). 2022 Jun 16;14(12):2966. doi: 10.3390/cancers14122966.
2
Shifting Paradigms in the Pathophysiology and Treatment of Carcinoid Crisis.类癌危象的病理生理学和治疗范式转变。
Ann Surg Oncol. 2022 May;29(5):3072-3084. doi: 10.1245/s10434-022-11371-0. Epub 2022 Feb 14.
3
The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors.
北美神经内分泌肿瘤学会关于胰腺神经内分泌肿瘤手术治疗的共识文件。
Pancreas. 2020 Jan;49(1):1-33. doi: 10.1097/MPA.0000000000001454.
4
The Treatment of Liver Metastases in Patients with Neuroendocrine Tumors in 2012.2012年神经内分泌肿瘤患者肝转移的治疗
ISRN Hepatol. 2013 Feb 14;2013:702167. doi: 10.1155/2013/702167. eCollection 2013.
5
Gastroenteropancreatic neuroendocrine tumors: diagnosis and treatment.胃肠胰神经内分泌肿瘤:诊断与治疗
Ann Gastroenterol. 2013;26(1):29-36.
6
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).胃肠胰神经内分泌(包括类癌)肿瘤(NETs)管理指南。
Gut. 2012 Jan;61(1):6-32. doi: 10.1136/gutjnl-2011-300831. Epub 2011 Nov 3.
7
Recent trends in the treatment of well-differentiated endocrine carcinoma of the small bowel.近期分化型小肠内分泌癌治疗趋势。
World J Gastroenterol. 2010 Apr 14;16(14):1696-706. doi: 10.3748/wjg.v16.i14.1696.
8
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.胃肠胰神经内分泌(包括类癌)肿瘤管理指南
Gut. 2005 Jun;54 Suppl 4(Suppl 4):iv1-16. doi: 10.1136/gut.2004.053314.
9
Epidural anaesthesia for transurethral resection of the prostate in a patient with carcinoid syndrome.
Can J Anaesth. 1990 Apr;37(3):349-52. doi: 10.1007/BF03005589.
10
The prophylactic use of octreotide in a patient with ovarian carcinoid and valvular heart disease.奥曲肽在一名患有卵巢类癌和心脏瓣膜病患者中的预防性应用。
Can J Anaesth. 1990 Oct;37(7):798-800. doi: 10.1007/BF03006540.